SUSAN ADKINS: Open Payments
NPI 1114693686 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 49 payments from 14 companies in 2025. Trend: 2023 $302 · 2024 $120 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $233 |
| Janssen Biotech, Inc. | 8 | $169 |
| Phathom Pharmaceuticals, Inc. | 4 | $167 |
| GENZYME CORPORATION | 5 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| QOL Medical, LLC | 4 | $115 |
| Intercept Pharmaceuticals, Inc. | 3 | $64 |
| PFIZER INC. | 2 | $40 |
| VIVUS LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: DUPIXENT, TREMFYA, VOQUEZNA, Sucraid, LINZESS, ENTYVIO, OCALIVA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
